Abstract
Sperm DNA damage is associated with poorer assisted reproductive treatment (ART) outcomes including reduced fertilization rates, embryo quality, and pregnancy rates and higher rates of spontaneous miscarriage and childhood diseases. It shows promise as a more robust biomarker of infertility than conventional semen parameters. Among the sperm DNA testing methods, the alkaline comet assay is a sensitive, reliable, and powerful tool to detect even low levels of DNA damage within individual sperm. The present chapter provides an overview of the use of the alkaline comet assay in sperm. This includes the need for standardization of the alkaline comet assay protocol and its present strengths and weaknesses. Since sperm DNA damage is often the result of increased oxidative stress in the male reproductive tract, primarily formed due to an imbalance between reactive oxygen species generation and antioxidant depletion, a novel addition to the comet assay to measure oxidized bases is explored. The potential use of antioxidant therapy to protect against such damage is also described. Finally, the diagnostic and prognostic values of sperm DNA damage measures in determining the assisted reproductive technology (ART) success are discussed.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Sperm comet assay
- Sperm DNA
- Assisted reproductive treatment
- • Comet assay
- Oxidative stress in male reproduction
The Need for Novel Diagnostic and Prognostic Tests
Male infertility is implicated in more than 40% of couples presenting for treatment with assisted reproductive technology (ART). Conventional semen analysis continues to be the only routine test to diagnose male infertility. However, semen analysis cannot discriminate between the sperm of fertile and infertile men [1]. Recent evidence has suggested that instability in the genomic material of the sperm nuclei is a more robust parameter in measuring the fertility potential of sperm, either in vivo or in vitro. For a test to be useful diagnostically or prognostically, it must have a threshold value that provides a discriminatory power above or below the threshold value with little overlap between groups of fertile and infertile men and couples with ART success and failure. However, neither the routine semen analysis nor the available sperm DNA tests yet meet these standards (reviewed in references [2, 3]).
The primary function of the sperm is to deliver the paternal genome to the oocyte. Recent studies have shown a number of sperm nuclear abnormalities such as DNA strand breaks, Y chromosome microdeletions, alterations in chromosome number, distorted epigenetic regulation and sperm’s environmental milieu during epididymal transport and ejaculation. Factors such as increased oxidative stress or low levels of antioxidants may have implications on male reproductive health [4]. As the structural organization of the sperm chromatin is also essential for the normal function of the sperm [5], characterization of sperm DNA quality has gained importance. In recent years, comet assay, TUNEL, SCSA, and SCDA or Halo assay, in situ nick end labeling have been studied extensively to analyze sperm chromatin integrity. Each of these tests determines different aspects of DNA integrity, but to date, combining all the studies available in meta-analysis shows that these tests lack the statistical power and diagnostic potential necessary to incorporate them into routine clinical use.
Causes of Sperm DNA Damage
In recent years, the generation of reactive oxygen species (ROS) has been widely studied in the male reproductive tract and reported to be a concern because of their toxic effects on sperm quality and function (reviewed by Saleh and Agarwal [6]). They have been shown to cause DNA fragmentation in the reproductive tract as well as damage in ejaculated sperm [7]. High levels of ROS have also been reported in the seminal plasma of infertile men [8]. Sperm are vulnerable to the oxidative-stress-mediated damage, due to their structure with a high proportion of polyunsaturated fatty acids in their plasma membranes [9]. As sperm cannot repair such damage, sperm DNA has evolved to protect itself by compact packaging of the sperm DNA by protamines [10, 11].
The exact mechanisms by which ROS induces DNA damage are poorly understood, However, ROS-induced sperm DNA damage is exemplified by DNA cross-links, frameshifts, production of base free sites, chromosomal rearrangements and DNA base-pair oxidation [12–14]. It is also well known to cause strand breaks, with the levels of ROS correlated with increased percentage of single and double-strand damage in sperm [15–17]. ROS-mediated DNA damage is also seen in the formation of modified bases, which are often converted into strand breaks and considered to be important biomarkers for oxidative DNA damage [18]. Finally, ROS cause gene mutations such as point mutations and polymorphism [19, 20].
Seminal plasma is contaminated with ROS [21, 22] primarily produced by leukocytes and defective sperm [23]. The presence of elevated levels (>1 × 106/mL) of leukocytes in the semen is defined as leukocytospermia [24] and is associated with increased levels of ROS, leading to sperm DNA damage [25]. Cytoplasmic droplets are also associated increased ROS generation and poor sperm quality [26, 27].
Environmental and Lifestyle Hazards
It has recently been reported that male fertility declines with age, even though spermatogenesis continues [28]. An increase in male age has been associated with increased genetic and chromosomal defects [29, 30]. Men over 37 years have been shown to three times more sperm DNA damage then men aged <37 years [31, 32]. Male germ cells are particularly vulnerable to environmental chemicals and xenobiotics that cause DNA damage [33]. Studies also show the adverse impact of some occupations to increase the sperm DNA damage, for example among coke oven workers [34]. Oh et al. [35] concluded that there are elevated levels of DNA damage among waste incineration workers, when compared with men from similar origin. Further, men working in the factories with organic molecules such as styrene show a significant amount of increase in sperm DNA damage [36]. Similarly, men working in the insecticide and pesticide industries have higher levels of sperm DNA damage [37, 38].
A further hazard for sperm DNA is by pharmacological exposure to drugs. This has become very common as molecular medicine advances, especially in the field of cancer. Chemothera-peutic drugs are genotoxic to the male germ cells. A well-known example for such an intervention is the cyclophosphamide [39, 40] in animal model. Hellman et al.’s [41] cyclophosphamide treatment resulted in a five fold increase in DNA damage. Environmental exposure of xenobiotics cannot be avoided in our contemporary lifestyle because these pollutants are present in our food, water, and air. Studies have shown the association between environmental estrogens and derived compounds and male infertility through elevated sperm DNA damage [42]. Environmental pollutants such as organochlorides [43] and smog [44] also have the ability to induce DNA damage. Bennetts et al. [45] showed that estrogenic compounds such as 2-hydroxyestradiol induce redox cycling activities and concomitant sperm DNA damage. These examples support the belief that exposure to xenobiotics has powerful impacts on sperm DNA and sperm functions, leading to male infertility.
Lifestyle choices also play an important role in male infertility. For example, smoking and consumption of alcohol and caffeine have been associated to the increase in nuclear DNA damage of the white blood cells [46, 47]; on the contrary, very little is known about their effect on sperm DNA [48]. There is a very strong and significant correlation between smoking and genetic defects in the sperm [49, 50]. Smoking increases oxidative stress, which results in depletion of antioxidants in the seminal plasma, thereby inducing oxidative DNA damage to the sperm [15] and mutagenic adducts [51]. Recent studies have also suggested a possible link between cell-phone use associated with electromagnetic radiations and sperm DNA damage [52–56]. Finally, physical factors such as mild scrotal heating [57] and radio frequencies [55] have also been proven to diminish sperm DNA integrity.
The Comet Assay: What Does It Measure?
For a sperm DNA test to be clinically useful, (a) it should measure both single- and double-strand breaks, as both may be important and the oocyte has limited ability to repair fragmented paternal DNA, (b) it should measure the level of DNA fragmentation in each sperm, as an ejaculate is known to show a high degree of variation, (c) the methodology should be appropriate for cell lysis and DNA decondensation for full extent of damage to be determined, (d) the test must have strong predictive capacity for pregnancy outcome and little overlap between fertile and infertile samples. Among the tests currently available, the alkaline comet assay addresses the first three above-mentioned issues but useful thresholds have not been established yet to validate the assay.
Initially, the comet assay [58] was designed to characterize the structure of the nucleus. However, when electrophoresis of DNA strands after alkaline denaturation came into existence in 1988 by Singh et al., the detection of DNA damage within the nucleus became a possibility. Collins et al. [59] suggested that the migrated comet tail after electrophoresis consists of fragments originated from relaxation of supercoiled loops and single-stranded DNA formed under alkaline conditions. Some studies suggest that double-strand DNA breaks alone may be detected under neutral conditions (pH 8–9) [60, 61], and in these studies the level of measurable DNA damage is low compared to the alkaline comet assay. This is due to either the measurement of additional DNA damage by the alkaline condition or the relatively higher migration of DNA strands under alkaline conditions [62].
The extent of DNA damage in individual cells could be monitored by the use of image analyzing system. Presently, different commercial software packages are available to measure the comet parameters. A fully automated comet analyzing system has also been developed [63]. In the past, different methodologies were used to measure the extent of DNA damage such as the proportion of cells with altered tail DNA migration, approaches classifying comets into several categories based on the tail migration [64, 65]. However, these approaches are generally limited to electrophoretic conditions. Hughes et al. [66] reported that the evidence for intact DNA is considered more important in relation to fertility status than measurement of other comet parameters that could be altered by the experiment conditions.
The commonly used comet parameters are percentage head DNA, percentage tail DNA, tail length, and olive tail moment. The software system analyzes the light intensities (fluorescence) in the head relative to the tail to determine the percentage of DNA present in the head and tail. The background light intensity is subtracted from head and tail intensities to get the actual value. Also, the sperm populations are known to be more heterogeneous, and the baseline values of DNA damage of sperm population in an ejaculate are substantially higher than those in somatic cells [67]. Although, few number of sperm could be analyzed in the comet assay, Hughes et al. [66] demonstrated that the analysis of 50 sperm is sufficient to provide a measurement of DNA damage of the total sperm population with a coefficients of variation lower than 4%.
The comet assay is highly sensitive to detect extensive fragmented cell in the form of nonexistent heads or a large diffused tail termed as “ghost” or “clouds” or “hedgehogs” [68]. In such cases, the comet image system cannot interpret the full extent of DNA damage [69]; therefore, it is advisable to consider the ghosts as completely damaged cells. In sperm, such highly damaged cells should not be excluded during analysis [70]. The DNA-specific fluorescent dyes are used for comet visualization. The most frequently used fluorescent dyes are ethidium bromide, propidium iodide, DAPI, SYBR Green I, and benzoxazolium-4-quinolinum oxazole yellow homodimer [71]. Addition of an antifade reagent along with fluorescent dyes could significantly reduce fluorescence quenching [72]. Nofluorescent dyes such as silver nitrate are also reported for comet assay; however, the efficiency of the assay is reduced [73]. Excess of fluorescence dye could increase the background intensity of the slides thereby very low-molecular-weight DNA fragments could not be measured. Hence, standardization of the comet assay is required for accurate performance.
Strengths of Comet Assay
The comet assay is one of the most sensitive techniques available to measure DNA damage, and according to Aravindan et al. [74], the results of comet assay are also related to the results obtained from the TUNEL assay. The alkaline comet assay could be used in all the cell types and also in the sperm [75]. The assay requires only a few numbers of cells; hence, the assay is possible in cases of oligospermia and testicular biopsy. The DNA damage data can be collected at the level of individual cells, making the analysis efficient. The removal of protamines and histones during the assay reveals the total DNA damage in the cell. The range of DNA damage measured in sperm using the alkaline comet assay varies from 0–100% showing its capacity to identify sperm with much or little damage. A further advantage is that, unlike the TUNEL and SCSA, which detect primarily breaks in histone-associated chromatin, the comet assay has a broader use in detecting breaks in both protamine- and histone-bound chromatin equally.
Weaknesses of Comet Assay
One disadvantage of the comet assay is that it lacks standardized protocols, which makes it difficult to combine the results from different laboratories [76]. This should be resolved by agreement on an optimal protocol (see next section). The assay is criticized for the use of high pH conditions, which is known to denature the alkaline-labile sites measurable after electrophoresis [77], making it difficult to discriminate between endogenous and induced DNA breaks. However, labile sites may be considered as another form of potential damage, and some consider this as a strength, in that an indication of existing and potential damage may be more important clinically. The assay is also criticized for an underestimation of DNA damage that may occur through entangling of DNA strands or the presence of proteins and cross-linked DNA strands, which could restrict the movement of DNA fragments during electrophoresis. In some protocols, incomplete chromatin decondensation will not allow all strand breaks to be revealed. Overlapping comet tails decrease the accuracy of the assay, and few small tail fragments are lost or too small fragments are difficult to be visualized. As in other DNA tests, strong reducing agents are sometimes used to remove protamines, and they may increase what is perceived to be baseline damage. Also, the assay requires a laborious process of analysis and shows high interlaboratory variation and, hence, is not used clinically [78]. Owing to a labor-intensive and sensitive protocol, the assay requires skilled technicians for accuracy. Finally, the available software to measure DNA damage cannot recognize “Ghost cells” without head DNA and overlapping comet tails, making the scoring difficult. However, most of these weaknesses can be corrected with appropriate protocols and training.
Need for Standardized Methodology for the Comet
The comet assay is currently used primarily for genotoxic studies, although it is a test with great potential for ART [79]. For use with sperm, a number of academic and methodological issues need to be addressed, as there is no generally accepted protocol for the assay, even though international groups of scientists [53, 80–82] have used it extensively.
The first variation relates to lysis conditions. Absence of cytoplasm in sperm makes it difficult to optimize lysis conditions compared to the somatic cells. For example, in some labs, lysis of plasma membranes is performed by incubating cells with a buffer (usually containing Proteinase K, Triton X-100, and high concentrations of NaCl) for a short time (3 h), in others a long, even overnight period (18 h) [83–85].
As discussed previously, the sperm genomic DNA is more highly condensed than somatic cells preventing the migration of the comet tail, so for use with sperm it requires the use of additional steps to decondense the tightly packed DNA. A wide range of strong reagents (Proteinase K, Triton X-100, Dimethyl Sulfoxide, DTT, and LIS) have been used to remove protamines and histones [67, 83, 84, 86–88], but these agents may also induce damage. The presence of these different approaches prevents interlaboratory comparisons.
To reduce the level of laboratory-induced damage and make the assay more reproducible, our group has replaced Proteinase K with DTT and LIS and for a shorter duration of 3 h [85].
Another difference between labs is the pH at which the assay is performed. Currently, electrophoresis is carried out with wide range of buffers with pH ranging from pH 8.0 to 13.5 [66, 67, 84–86, 89]. Such a wide range of pH conditions again makes results difficult to compare, as the extent of DNA migration is highly influenced by the degree of alkali denaturation and the pH value.
A further confusion from “comet” studies comes from the lack of standardization of comet parameters described in different studies. There are several parameters used in comet studies. McKelvey et al. [90] described it as “DNA migration can be determined visually by the categorization of comets into different “classes” of migration. The percentage of DNA in the tail (percent migrated DNA), tail length and tail moment (fraction of migrated DNA multiplied by some measure of tail length). Of these, tail moment and/or tail length measurements are the most commonly reported, but there is much to recommend the use of per cent DNA in tail, as this gives a clear indication of the appearance of the comets and, in addition, is linearly related to the DNA break frequency over a wide range of levels of damage. The approach or parameter used must be clearly defined and, if not typical, be justified.”
Hughes et al. [67] recommended the use of percent tail DNA, as its coefficients of variation was less than 4%. Measurement of fifty comets from a single slide is reported to have a coefficient of variation of less than 6% within a sperm population [67]. They also reported the reproducibility of the image analysis software with repeated analysis of individual sample showed a coefficient of variation of less than 5.4%.
Tice et al. [71] recommended the measurement of tail length, percent tail DNA and tail moment, finding different results between tail DNA and tail moment. However, Kumaravel and Jha [91] did not find any statistical difference with olive tail moment and percentage tail DNA to analyze the extent of DNA damage. The percentage of tail DNA is reported to be directly proportional to the dosage of radiation and concentration of hydrogen peroxide. By contrast, the olive tail moment is highly influenced by the study conditions, so it is not consistent between labs and, thus, not advisable for use.
In summary, agreement on a standardized protocol for the comet to necessary to compare results between groups. To reduce the additional DNA damage caused during the assay procedure, the duration of lysis, the composition of the lysis buffer, the method of decondensation, the pH for unwinding, and electrophoresis condition and parameters to be reported should be standardized.
Clinical Significance of DNA Fragmentation Measured by the Comet Assay
The alkaline comet assay is proving to be a useful diagnostic tool for male infertility. The clinical importance of the comet assay in assessing male infertility has been demonstrated by a number of authors [79, 92–94]. However, until recently, its predictive value in assisted reproduction outcome has been assessed by few [86, 95].
In a recent study from our group [82] of 360 couples having IVF or ICSI we reported that sperm DNA damage is associated with poorer ART outcomes and promises to be a more robust biomarker of infertility than conventional semen parameters. We found significant inverse correlations between DNA fragmentation, fertilization rate, and embryo quality assessed by the alkaline comet assay (to detect both double and single strand breaks) following IVF treatment. A decrease in fertilization rates were observed as DNA damage of native semen and DGC sperm increased. Low DNA damage (0–20%) showed a significantly higher fertilization rate compared with DNA damage >60%. Our work supports that of Morris et al. [88] who also reported a significant correlation between fertilization and DNA damage when measured by the neutral comet assay (measuring double-strand breaks only). However, by contrast, no correlations were observed between fertilization rates and DNA fragmentation measured in alkaline comet assay by Tomsu et al. [95].
Our study [82] also showed a decrease in embryo quality following IVF treatment, as DNA fragmentation increased both in native semen and DGC sperm. The embryo quality showed a significant decrease, when DNA damage was greater than 60% in the native semen. The embryo cumulative score calculated according to Steer et al. [96] was 15.5 in the group where sperm DNA fragmentation was <20% and was only 7.3 where sperm DNA fragmentation was >60% in DGC sperm. Similarly, Tomsu et al. [95] showed a negative correlation between embryo quality and DNA fragmentation in both the native semen and the DGC sperm. However, Morris et al. [88] did not find any association in embryo quality and DNA damage. In contrast to associations following IVF, we did not find any correlation between sperm DNA damage and fertilization rate or embryo quality when ICSI was used as a treatment of choice [82].
Using pregnancy as the outcome measure, Morris et al. [88] did not find an association between clinical pregnancy and sperm DNA fragmentation measured by the neutral comet assay. Similarly, Tomsu et al. [95] in a small study (n = 40) no associations were found. However, we found a significant difference in DNA fragmentation of clinically pregnant and nonpregnant couples following IVF [82]. By contrast, although couples undergoing ICSI who failed to achieve a clinical pregnancy tended to have more DNA fragmentation but it was not statistically significant.
Further Uses of the Comet to Measure DNA Adducts
A major cause of sperm DNA damage is oxidative stress due to the generation of the ROS from contaminating leukocytes, defective sperm, and antioxidant depletion [23, 97]. FPG is the commonly used bacterial repair enzyme that could recognize and excise 8-OHdG and other modified bases generated by ROS. This FPG enzyme has been shown to possess affinities toward the various modified DNA bases [98, 99]. The catalytic activity of FPG involves a three-step process: (a) hydrolysis of the glycosidic bond between the damaged base and the deoxyribose, (b) incision of DNA at abasic sites, leaving a gap at the 3′ and 5′ ends by phosphoryl groups, and (c) removal of terminal deoxyribose 5′-phosphate from 5′ terminal site to excise the damaged base showed by Kuznetsov [100].
When a eukaryotic or prokaryotic base repair enzyme or glycosylase is introduced as an intermediate step during the alkaline comet assay, the modified bases can be converted into single-strand breaks [101, 102]. Addition of base repair enzymes can increase the sensitivity of the assay by including the modified bases, resulting in total DNA damage measured after the alkaline comet assay [103]. Among the modified bases, 8-OHdG is the most commonly studied biomarker and is often selected as a representative of oxidative DNA damage due to its high specificity, potent mutagenicity, and relative abundance in DNA [33, 104]
Clinical Significance of Existing Strand Breaks Plus Adducts Measured by the Comet Assay
To analyze modified bases in the sperm DNA, we have used the prokaryotic repair enzyme (FPG) as an intermediate step during the alkaline comet assay, to introduce breaks at sites of modified bases [82]. We found inverse relationships between total DNA damage (existing strand breaks plus modified bases) and IVF and ICSI outcomes after conversion of modified bases to DNA strand breaks by FPG. There was a significant increase in DNA damage after treatment with the DNA glycosylase FPG in both native and DGC samples. In the IVF patients, addition of the FPG enzyme showed a significant increase in mean percentage of sperm DNA fragmentation in nonpregnant compared with that from pregnant couples (55 vs. 72) in the native semen and (42 vs. 56) in DGC sperm. Similarly, in ICSI couples, when modified bases were included, the percent DNA damage between pregnant and nonpregnant couples was markedly different (63 vs. 80 in native semen, and 50 vs. 65 in DGC sperm), in contrast to comet assay without FPG where it was not significant.
The Risks of Using Sperm with Damaged DNA
Sperm DNA damage measured by SCSA, TUNEL, and alkaline and neutral comet assays has been closely associated with all the stages of ART outcome such as fertilization, embryo quality, implantation pregnancy, and spontaneous abortion [105, 106]. A limited amount of sperm DNA damage can be repaired by the oocyte post fertilization, but above a threshold limit this process is either incomplete or inappropriate, resulting in genetic mutations and may impact the viability of the embryo and the health of the offspring [107]. Men suffering from male infertility have high levels of sperm with DNA damage, which result in an negative impact on their ART outcome [25, 108–112].
In recent years, sperm DNA damage has gained interest to understand the fertilization process to improve fertility diagnostics. The influence of DNA damage on fertilization rates in assisted reproduction is still controversial. A number of papers have analyzed the possible association between sperm DNA damage and fertilization rates in vitro [16, 106, 111, 113–127]. But, many of these papers suggest that sperm DNA damage does not affect fertilization rates [106, 111, 115, 117–120, 126, 127]. Sperm with damaged DNA are still capable of fertilization [93] but its effect is prominent in the later stages [128]. Sperm with abnormal chromatin packing and DNA damage is showed to result in decondensation failure, which results in fertilization failure [25]. It is also showed that that a significantly proportion of nondecondensed sperm in human oocytes has a higher DNA damage, compared to decondensed sperm and higher degree of chromatin damage, this may prevent the initiation or completion of decondensation, and may be an important factor leading to a failure in fertilization [129]. A negative correlation between the proportion of sperm having DNA strand breaks and the proportion of oocytes fertilized after IVF is established [114].
Measurement of sperm DNA damage has been shown to have a significant negative effect on the developing embryo [130]. Poor sperm DNA quality is associated with poor blastocyst development and the failure to achieve a clinical pregnancy. Sperm DNA damage has a significant impact on embryo development [16, 95, 105, 114, 126, 129, 131–133]. However, a number of studies have contradicted the influence of DNA damage on embryo development [106, 108, 109, 112, 115–119, 122, 123, 126, 127]. Abnormalities in the embryo seen in vitro can be more directly related to male factors because the results can be assessed without the interference of female factors such as uterine and endocrine abnormalities that may lead to miscarriage after embryo transfer [134]. The embryonic genome is activated on day three, and its transcriptional products take over from the regulatory control provided by maternal messages stored in the oocyte [132]. The effect of sperm DNA damage has been attributed to embryo development, particularly between four and eight cell stage of preimplantation development until which the embryonic genome is transcriptionally inactivated and the paternal genome plays a significant contributory role in embryo function during the transcriptional activity [133]. Therefore, the effect of sperm DNA damage impacts more on pregnancy rates than embryo quality [115].
Couples who failed to achieve a pregnancy are known to have a higher mean level of DNA fragmentation than pregnant couple after IVF treatment [105, 112, 115, 118–120, 122, 133, 135]. This implies that sperm with DNA fragmentation can still fertilize an oocyte but that when paternal genes are “switched on,” further embryonic development stops, resulting in failed pregnancy [121]. In contrast to these reports, no significant association between sperm DNA damage and clinical pregnancies has been reported [88, 95, 114, 116, 123, 124, 126, 127, 136, 137]. Studies using animal models show that oocytes and developing embryos can repair sperm DNA damage; however, there is a threshold beyond which sperm DNA cannot be repaired [138]. They also reported that sperm with defective DNA can fertilize an oocyte and produce high-quality early-stage embryos, but then, as the extent of the DNA damage increases, the likelihood of a successful pregnancy decreases. Virro et al. [132] have shown that high levels of sperm DNA damage significantly decrease the pregnancy rates and results in higher rate of spontaneous abortions. An increase in sperm DNA damage is associated with decreased implantation, thereby a decrease in pregnancy rates [118]. By contrast, Bungum et al. [136] and Boe-Hansen et al. [137] showed a decrease in implantation rates with increase in DNA damage but no effect is seen on clinical pregnancies. Frydman et al. [106] showed increase in DNA damage not only decrease implantation and pregnancy rates but also increase spontaneous miscarriage rates. Lin et al. [127] also observed an increase in miscarriage rates with an increase in DNA damage.
It is also shown that damage in the paternal genome could result in abnormalities occur during postimplantation development [139]. Genetic abnormalities in the paternal genome in the form of strand breaks are a significant cause of miscarriages [134]. Sperm DNA damage could likely be the cause of infertility in a large percentage of patients [140]. However, these studies may not causal, but simply associations between DNA damage and reduced ART outcomes. Are the tests clinically useful?
The Clinical Usefulness of the Comet Test
Two recent systematic reviews have shown that the impact of sperm DNA damage on ART outcomes decreases from IUI to IVF and is least useful in ICSI [3, 141]. In IVF, using TUNEL and SCSA assays, the odds ratios is 1.57 (95% CI 1.18–2.07; p < 0.05). However, in our study using the alkaline comet [82] we obtained an odds ratio of 4.52 (1.79–11.92) in native semen and 6.20 (1.74–26.30) in DGC sperm for clinical pregnancy following IVF, indicating its promise as a prognostic test. Owing to the high sensitivity of the test and level of damage observed when both strand breaks and modified bases were measured it was not possible to establish thresholds for our novel combined test. Following ICSI, the odds ratio for clinical pregnancy was 1.97 (0.81–4.77) using native semen and 2.08 (0.93-4.68) in DGC sperm showing less strength and supporting the combined odds ratio of 1.14 from the meta-analyses by Collins et al. [141] and Zini and Sigman [3]. This supports the belief that ICSI bypasses genetic, as well as functional defects, but the results are counterintuitive. Given the many animal studies showing adverse effects of DNA damage on the long-term health of offspring (reviewed by Aitken et al. [142]; Fernadez-Gonzalez et al. [143]), we need to follow-up the children born by ISCI to make sure that this genetic heritage does not have long-term adverse effects of these children’s health even if short-term success in terms of pregnancies is achieved.
Two People but Just One Prognostic Test
The quest for one perfect test to predict a outcome with multifactorial input is particularly unachievable when this outcome involves not just one individual but, in the case of ART, two partners. Since female factors such as age, occyte and embryo quality, and uterine competence all impact significantly on pregnancy, it is not surprising that if one test on the male partner is not acceptably strong. The current literature exemplifies how the controversies as to the usefulness of sperm DNA testing are exacerbated by flawed experimental design. Couples undergoing IVF treatment can be divided into those with female, male, and unexplained infertility. A large proportion of couples undergoing IVF treatment are due to female causes.
In many studies, couples with male, female, and idiopathic infertility have been grouped together. In order to assess the clinical usefulness of a test for one partner of the infertile couple, the appropriate patient population should be identified. Future studies should be designed to minimize the variation in these female factors. Only then can we accurately determine the effects of sperm DNA and thereby maximize the usefulness of the test.
Protection of DNA from Damage
In the male reproductive tract, oxidative stress is due to the increase in the production of ROS, rather than the decrease in the seminal antioxidants. Owing to the lack of cytoplasm excluded during spermatogenesis, there is no self DNA repair mechanism in the sperm; therefore, antioxidants in the seminal plasma are essential to reduce the oxidative stress, and it is the only available mechanism for the sperm to protest against oxidative-stress-mediated DNA damage. Naturally, the concentration of antioxidants in seminal plasma is 10 times greater than in blood plasma [144], and the presence of antioxidants in the seminal plasma protects the functional integrity of the sperm against the oxidative stress [145]. Several other studies showed the role of antioxidants against ROS [21, 146–148]. However, some studies show limited protection of antioxidants against induced ROS [149].
Low levels of antioxidants in semen are associated with suboptimal semen parameters (Kao et al. [189]) and increased sperm DNA damage [150]. Oral administration of the antioxidants has been shown to significantly increase antioxidant levels in the seminal plasma and an improvement in the semen quality [151–155]. Specifically, antioxidant treatment to infertile patients by oral administration of vitamins significantly improved their sperm motility [152, 154, 156–158], sperm concentration [12, 159, 160], and normal morphology of the sperm [152, 159]. Improvement in semen parameters by administration of oral antioxidants were seen in volunteers as well as patients [154, 161]. Studies by Lenzi et al. [162–164] reported a protective function of antioxidants on semen quality due to a reduction of ROS and a reduction in the lipid peroxidation of the membrane. By contrast, other studies have shown no significant effects of oral antioxidant treatment on semen parameters [165–167]. The absence of effects in these studies may be due to shorter duration of treatment [167, 168] and/or very low dosage of antioxidants used [169].
Administration of oral antioxidants had been shown to significantly decrease sperm DNA damage [12, 170–173] and to reduce sperm DNA adducts [174] and the incidence of aneuploidy in sperm [175], thereby increasing the assisted reproductive success [176, 177].
Protection of sperm from DNA damage should also be monitored during sperm processing and cryopreservation when they are especially vulnerable. The absence of antioxidant protection in these procedures has been shown to increase sperm DNA damage [15]. Zalata et al. [178] showed that high-speed centrifugation and removal of sperm from the protective seminal plasma resulted in ROS-mediated DNA damage. Addition of antioxidants in the sperm medium could decrease oxidative stress [179] and damage to sperm [180]. Donnelly et al. [181] showed that addition of vitamins in the sperm suspension media could protect the sperm from DNA damage. This in turn would have a positive effect on male infertility [174]. Cryopreservation of sperm is known to increase the level of sperm DNA damage [93, 182–184].
Oxidative stress occurs when the level of ROS exceeds the antioxidant protection resulting in sperm DNA damage. Approximately, half of infertile men exhibit oxidative stress [185]. In light of these considerations, future research to determine the best regime of antioxidant therapy so be pursued to find an effective treatment [186–188].
Conclusions and Future Recommendations
Clinical evidence shows the negative impact of sperm DNA fragmentation on reproductive outcomes, and sperm from infertile men show higher levels of DNA fragmentation than the sperm of fertile or donor men. Recent studies have shown that the use of alkaline comet assay to test sperm DNA fragmentation is a useful tool for male infertility diagnosis and early predictor of ART outcomes. Below novel “comet” threshold values of sperm DNA fragmentation in both native semen and DGC sperm obtained from the alkaline comet assay, there is evidence of infertility in vivo and in vitro. Therefore, it is beneficial to assess sperm DNA fragmentation in couples presenting with infertility problems and also in patients undergoing ART. We encourage studies to analyze the impact of sperm DNA fragmentation and to validate the current protocol of the alkaline comet assay through large multicenter trials, using good quality control, with standardized protocols.
Abbreviations
- DAPI:
-
4,6-Diamidino-2-phenylindole
- 8-OHdG:
-
8-Hydroxy-2-deoxyguanosine
- ART:
-
Assisted reproductive technology
- DGC:
-
Density-gradient centrifugation
- DTT:
-
Dithiothreitol
- FPG:
-
Formamidopyrimidine-DNA glycosylase
- IVF:
-
In vitro fertilization
- ICSI:
-
Intracytoplasmic sperm injection
- LIS:
-
Lithium diiodosalicyclate
- ROS:
-
Reactive oxygen species
- SCDS:
-
Sperm chromatin dispersion assay
- SCSA:
-
Sperm chromatin structure assays
- TUNEL:
-
Terminal deoxynucleotidyl transferase dUTP nick end labeling
References
Guzick DS, Verstreet JWO, Factor-Litvak P, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345(19):1388–93.
Lewis SEM. Is sperm evaluation useful in predicting human fertility? Reproduction. 2007;134:31–40.
Zini A, Sigman M. Are tests of sperm DNA damage clinically useful? Pros and cons. J Androl. 2009;30(3):219–29.
Agarwal A, Prabakaran SA. Mechanism, measurement and prevention of oxidative stress in male reproductive physiology. Ind J Exp Biol. 2005;43:963–74.
Ward WS, Coffey DS. DNA packaging and organization in mammalian spermatozoa: comparison with somatic cell. Biol Reprod. 1991;44:569–74.
Saleh R, Agarwal A. Oxidative stress and male infertility: from research bench to clinical practice. J Androl. 2002;23:737–52.
Barroso G, Morshedi M, Oehringer S. Analysis of DNA fragmentation, plasma membrane translocation of phosphatidylserine and oxidative stress in human spermatozoa. Hum Reprod. 2000;15:1338–44.
Padron OF, Brackett NL, Sharma RK, et al. Seminal reactive oxygen species, sperm motility and morphology in men with spinal cord injury. Fertil Steril. 1997;67:115–1120.
Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology. 1996;48:835–50.
Balhorn R. A model for the structure of chromatin in mammalian sperm. J Cell Biol. 1982;93:298–305.
Brewer LR, Corzett M, Balhorn R. Protamine-induced condensation and decondensation of the same DNA molecule. Science. 1999;286:120–3.
Kodama H, Yamaguchi R, Fukuda J, et al. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril. 1997;68:519–24.
Twigg J, Fulton N, Gomez E, et al. Analysis of the impact of intracellular reactive oxygen species generation on the structural and functional integrity of the human spermatozoa: lipid peroxidation, DNA fragmentation and effectiveness of antioxidants. Hum Reprod. 1998;13:1429–36.
Duru NK, Morshedi M, Oehninger S. Effects of hydrogen peroxide on DNA and plasma membrane integrity of human spermatozoa. Fertil Steril. 2000;74:1200–7.
Fraga CG, Motchnik PA, Wyrobek AJ, et al. Smoking and low antioxidant levels increase oxidative damage to sperm DNA. Mutat Res. 1996;351:199–203.
Sun JG, Jurisicova A, Casper RF. Detection of deoxyribonucleic acid fragmentation in human sperm: correlation with fertilization In Vitro. Biol Reprod. 1997;56:602–7.
Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction. 2001;122:497–506.
Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative disease and aging. Proc Natl Acad Sci USA. 1993;90:7915–22.
Spiropoulos J, Turnbull DM, Chinnery PF. Can mitochondrial DNA mutations cause sperm dysfunction? Mol Hum Reprod. 2002;8:719–21.
Sharma RK, Said T, Agarwal A. Sperm DNA damage and its clinical relevance in assessing reproductive outcome. Asian J Androl. 2004;6:139–48.
Aitken RJ. Free radicals, lipid peroxidation and sperm function. Reprod Fertil Dev. 1995;7:659–68.
Lopes S, Jurisicova A, Sun J, et al. Reactive oxygen species: a potential cause for DNA fragmentation in human spermatozoa. Hum Reprod. 1998;13:896–900.
Garrido N, Meseguer M, Simon C, et al. Pro-oxidative and anti-oxidative imbalance in human semen and its relation with male fertility. Asian J Androl. 2004;6:59–65.
Thomas J, Fishel SB, Hall JA, et al. Increased polymorphonuclear granulocytes in seminal plasma in relation to sperm morphology. Hum Reprod. 1997;12:2418–21.
Lopes S, Sun JG, Jurisicova A, et al. Sperm deoxyribonucleic acid fragmentation is increased in poorquality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection. Fertil Steril. 1998;69(3):528–32.
Gomez E, Buckingham DW, Brindle J, et al. Development of an image analysis system to monitor the retention of residual cytoplasm by human spermatozoa: correlation with biochemical markers of the cytoplasmic space, oxidative stress, and sperm function. J Androl. 1996;17:276–87.
Agarwal A, Makker K, Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol. 2008;59:2–11.
Sloter E, Nath J, Eskenazi B, et al. Effects of male age on the frequencies of germinal and heritable chromosomal abnormalities in humans and rodents. Fertil Steril. 2004;81(4):925–43.
Crow JF. The origins, patterns and implications of human spontaneous mutation. Nat Rev Genet. 2000;1(1):40–7.
Bosch M, Rajmil O, Egozcue J, et al. Linear increase of structural and numerical chromosome 9 abnormalities in human sperm regarding age. Eur J Hum Genet. 2003;11(10):754–9.
Singh NP, Muller CH, Berger RE. Effects of age on DNA doublestrand breaks and apoptosis in human sperm. Fertil Steril. 2003;80(6):1420–31.
Wyrobek AJ, Evenson D, Arnheim N, et al. Advancing male age increase the frequencies of sperm with DNA fragmentation and certain gene mutations, but not aneuploidies or diploidies. Proc Natl Acad Sci USA. 2006;103(25):9601–6.
Aitken R, de Iuliis GN. Origin and consequences of DNA damage in male germ cells. Reprod Biomed Online. 2007;14(6):727–33.
Hsu PC, Chen IY, Pan CH, et al. Sperm DNA damage correlates with polycyclic aromatic hydrocarbons biomarker in coke oven workers. Int Arch Occup Environ Health. 2006;79:349–56.
Oh E, Lee E, Im H, et al. Evaluation of immuno and reproductive toxicities and association between immunotoxicological and genotoxicological parameters in waste incineration workers. Toxicology. 2005;210:65–80.
Migliore L, Nacearali A, Zanello A, et al. Assessment of sperm DNA integrity in workers exposed to styrene. Hum Reprod. 2002;17:2912–8.
Bian Q, Xu LC, Wang SL. Study on the relation between occupational fenvalerate exposure and spermatozoa DNA damage of pesticide factory workers. Occup Environ Med. 2004;61:999–1005.
Xia Y, Cheng S, Bian Q, et al. Genotoxic effects on spermatozoa of carbaryl-exposed workers. Toxicol Sci. 2005;85:615–23.
Harrouk W, Codrington A, Vinson R, et al. Paternal exposure to cyclophosphamide induces DNA damage and alters the expression of DNA repair genes in the rat preimplantation embryo. Mutat Res. 2000;461(3):229–41.
Hales BF, Barlon TS, Robaire B. Impact of paternal exposure to chemotherapy on offspring in the rat. J Natl Cancer Inst Monogr. 2005;34:28–31.
Hellman B, Vaghef H, Bostrom B. The concepts of tail moment and tail inertia in the single electrophoresis assay. Mutat Res. 1995;336:123–31.
Anderson D. Overview of male-mediated developmental toxicity. Adv Exp Med Biol. 2003;518:11–24.
Spano M, Toft G, Hagmar L, et al. Exposure to PCB and p.p′-DDE in European and Inuit populations: impact on human sperm chromatin integrity. Hum Reprod. 2005;20:3488–99.
Evenson DP, Wixon R. Environmental toxicants cause sperm DNA fragmentation as detected by the sperm chromatin structure assay (SCSA(R)). Toxicol Appl Pharmacol. 2005;207:532–7.
Bennetts LE, de Iuliis GN, Nixon B, et al. Impact of estrogenic compounds on DNA integrity in human spermatozoa: evidence for cross-linking and redox cycling activities. Mutat Res. 2008;641:1–11.
Park E, Kang MH. Smoking and high plasma triglyceride levels as risk factors for oxidative DNA damage in the Korean population. Ann Nutr Metab. 2004;48(1):36–42.
Wyrobek AJ, Schmid TE, Marchetti F. Cross-species sperm-FISH assays for chemical testing and assessing paternal risk for chromosomally abnormal pregnancies. Environ Mol Mutagen. 2005;45:271–83.
Wyrobek AJ, Schmid TE, Marchetti F. Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies. J Natl Cancer Inst Monogr. 2005;34:31–5.
Rubes J, Lowe X, Moore DII, et al. Smoking cigarettes is associated with increased sperm disomy in teenage men. Fertil Steril. 1998;70(4):715–23.
Shi Q, Ko E, Barclay L, et al. Cigarette smoking and aneuploidy in human sperm. Mol Reprod Dev. 2001;59(4):417–21.
Zenzes MT. Smoking and reproduction: gene damage to human gametes and embryos. Hum Reprod Update. 2000;6:122–31.
Sykes PJ, McCallum BD, Bangay MJ, et al. Effect of exposure to 900 MHz radiofrequency radiation on intrachromosomal recombination in pKZ1 mice. Radiat Res. 2001;156:495–502.
Tice RR, Hook GG, Donner M, et al. Genotoxicity of radiofrequency signals. I. Investigation of DNA damage and micronuclei induction in cultured human blood cells. Bioelectromagnetics. 2002;23:113–26.
Mashevich M, Folkman D, Kesar A, et al. Exposure of human peripheral blood lymphocytes to electromagnetic fields associated with cellular phones leads to chromosomal instability. Bioelectromagnetics. 2003;24:82–90.
Aitken RJ, Bennetts LE, Sawyer D, et al. Impact of radio frequency electromagnetic radiation on DNA integrity in the male germline. Int J Androl. 2005;28:171–9.
Agarwal A, Desai N, Makker K, et al. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril. 2008;92(4):1318–25.
Banks S, King SA, Irvine DS, et al. Impact of a mild scrotal heat stress on DNA integrity in murine spermatozoa. Reproduction. 2005;129:505–14.
Cook PR, Brazell IA, Jost E. Characterization of nuclear structures containing superhelical DNA. J Cell Sci. 1976;22:303–24.
Collins AR, Dobson VL, Dusinska M, et al. The comet assay: what can it really tell us? Mutat Res. 1997;375:183–93.
Singh NP, Stephens RE. X-ray induced DNA double-strand breaks in human sperm. Mutagenesis. 1998;13:75–9.
McVicar CM, McClure N, Williamson K, et al. Incidence of Fas positivity and deoxyribonucleic acid double-stranded breaks in human ejaculated sperm. Fertil Steril. 2004;81(1):767–74.
Angelis KJ, Dusinska M, Collins AR. Single cell gel electrophoresis: detection of DNA damage at different levels of sensitivity. Electrophoresis. 1999;20:2133–8.
Bocker W, Rolf W, Bauch T, et al. Automated comet assay analysis. Cytometry. 1999;35:134–44.
Gedik CM, Ewen SWB, Collins AR. Single-cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol. 1992;62:313–20.
Kobayashi H, Sugiyama C, Morikawa Y, et al. A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay. MMS Commun. 1995;3:103–15.
Hughes CM, Lewis SEM, McKelvey-Martin VJ, et al. Reproducibility of human sperm DNA measurements using the alkaline single cell gel electrophoresis assay. Mutat Res. 1997;374:261–8.
Hughes CM, Lewis SEM, McKelvey-Martin VJ, et al. A comparison of baseline and induced DNA damage in human spermatozoa from fertile and infertile men, using a modified comet assay. Mol Hum Reprod. 1996;2:613–9.
Olive PL, Banath JP. Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp Cell Res. 1995;221:19–26.
Choucroun P, Gillet D, Dorange G, et al. Comet assay and early apoptosis. Mutat Res. 2001;478:89–96.
Sakkas D, Seli E, Bizzaro D, et al. Abnormal spermatozoa in the ejaculate: abortive apoptosis and faulty nuclear remodelling during spermatogenesis. Reprod Biomed Online. 2003;7:428–32.
Tice RR, Agurell E, Anderson D, et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 2000;35:206–21.
Tebbs RS, Pederson RA, Cleaver JE, et al. Modification of the comet assay for the detection of DNA strand breaks in extremely small samples. Mutagenesis. 1999;14:437–8.
Kizilian N, Wilkins RC, Reinhardt P, et al. Silver-stained comet assay for detection of apoptosis. Biotechniques. 1999;27:926–30.
Aravindan GR, Bjordhal J, Jost LK, et al. Susceptibility of human sperm to in situ DNA denaturation is strongly correlated with DNA strand breaks identified by single-cell electrophoresis. Exp Cell Res. 1997;10:231–7.
Singh NP, Danner DB, Tice RR, et al. Abundant alkali-sensitive sites in DNA of human and mouse sperm. Exp Cell Res. 1989;184:461–70.
Tarozzi N, Bizzaro D, Flamigni C, et al. Clinical relevance of sperm DNA damage in assisted reproduction. Reprod Biomed Online. 2007;14(6):746–57.
Fairbairn DW, Olive PL, O’Neill KL. The comet assay: a comprehensive review. Mutat Res. 1995;339:37–59.
Olive PL, Durand RE, Banath JP, et al. Analysis of DNA damage in individual cells. Methods Cell Biol. 2001;64:235–49.
Irvine DS, Twigg JP, Gordon EL, et al. DNA integrity in human spermatozoa: relationships with semen quality. J Androl. 2000;21:33–44.
Hartmann A, Agurell E, Beevers C, et al. Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis. 2003;18:45–51.
Burlinson B, Tice RR, Speit G, et al. Fourth International Workgroup on Genotoxicity testing: results of the in vivo Comet assay workgroup. Mutat Res. 2007;627:31–5.
Simon L, Lutton D, McManus J. Sheena EM. Lewis Clinical significance of sperm DNA damage in reproductive outcome. Hum Reprod. 2010;25(7):1594–608.
Haines GB, Daniel MP, Morris I. B, Daniel MP, Morris IDNA damage in human and mouse spermatozoa after in vitro-irradiation assessed by the comet assay. Adv Exp Med Biol. 1998;444:79–91.
Duty SM, Singh NP, Ryan L, et al. Reliability of the comet assay in cryopreserved human sperm. Hum Reprod. 2002;17:1274–80.
Baumgartner A, Schmid TE, Cemeli E, et al. Parallel evaluation of doxorubicin-induced genetic damage in human lymphocytes and sperm using the comet assay and spectral karyotyping. Mutagenesis. 2004;19:313–8.
Donnelly ET, McClure N, Lewis SE. Antioxidant supplementation in vitro does not improve human sperm motility. Fertil Steril. 1999;72:484–95.
Hughes CM, McKelvey-Martin VJ, Lewis SEM. Human sperm DNA integrity assessed by the Comet and ELISA assays. Mutagenesis. 1999;14:71–5.
Anderson D, Dobrzynska MM, Basaran N, et al. Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat Res. 1998;402:269–77.
Morris ID, Ilott S, Dixon L, et al. The spectrum of DNA damage in human sperm assessed by single cell gel electrophoresis (Comet assay) and its relationship to fertilization and embryo development. Hum Reprod. 2002;17:990–8.
Agbaje IM, Rogers DA, McVicar CM, et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod. 2007;22:1871–7.
McKelvey-Martin VJ, Green MHL, Schmezer P, et al. The single cell gel electrophoresis assay (COMET) assay: a European review. Mutagenesis. 1993;288:47–63.
Kumaravel TS, Jha AN. Reliable comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals. Mutat Res. 2006;605:7–16.
Chan PJ, Corselli JU, Patton WC, et al. A simple Comet assay for archived sperm correlates DNA fragmentation to reduced hyperactivation’ and penetration of zona-free hamster oocytes. Fertil Steril. 2001;75:186–92.
Donnelly ET, Steele EK, McClure N, et al. Assessment of DNA integrity. and morphology of ejaculated spermatozoa from fertile and infertile men before and after cryopreservation. Hum Reprod. 2001;16:1191–9.
Lewis SEM, Agbaje IM. Using the alkaline comet assay in prognostic test for male infertility and assisted reproductive technology outcome. Mutagenesis. 2008;23(3):163–70.
Tomsu M, Sharma V, Miller D. Embryo quality and IVF treatment outcomes may correlate with different sperm comet assay parameters. Hum Reprod. 2002;17:1856–62.
Steer CV, Mills CL, Tan SL, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme. Hum Reprod. 1992;7(l):117–9.
Lewis SEM, Boyle PM, McKinney KA, et al. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril. 1995;64:868–70.
Boiteux S, O’Connor TR, Lederer F. Homogeneous Escherichia coli FPG protein. A DNA glycosylase which excises imidazole ring-opened purines and nicks DNA at apurinic/apyrimidinic sites. J Biol Chem. 1990;265:3916–22.
Olsen AK, Duale N, Bjoras M, et al. Limited repair of 8-hydroxy-7,8-dihydroguanine residues in human testicular cells. Nucleic Acids Res. 2003;31:1351–63.
Kuznetsov SV, Sidorkina OM, Jurado J, et al. Effect of single mutations on the structural dynamics of a DNA repair enzyme, the Escherichia coli formamidopyrimidine-DNA glycosylase: A fluorescence study using tryptophan residues as reporter groups. Eur J Biochem. 1998;253:413–20.
Collins AR, Duthie SJ, Dobson VL. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis. 1993;14:1733–5.
Aukrust P, Luna L, Ueland T, et al. Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients. Blood. 2005;105:4730–5.
Collins AR, Ma AG, Duthie SJ. The kinetics of repair of oxidative DNA damage (strand breaks and oxidised pyrimidines) in human cells. Mutat Res. 1995;336:69–77.
Floyd RA. Tine role off 8-hydroxyguanine to carcinogenesis. Carcinogenesis. 1990;11(9):1447–50.
Saleh RA, Agarwal A, Nada EA, et al. Negative effects of increased sperm DNA damage in relation to seminal oxidative stress in men with idiopathic and male factor infertility. Fertil Steril. 2003;79(3):1597–606.
Frydman N, Prisant N, Hesters L, et al. Adequate ovarian follicular status does not prevent the decrease in pregnancy rates associated with high sperm DNA fragmentation. Fertil Steril. 2008;89(1):93–8.
Aitken RJ, Koopman P, Lewis SEM. Seeds of concern. Nature. 2004;432:48–52.
Larson KL, de Jonge CJ, Barnes AM, et al. Sperm chromatin structure assay parameters as predicted of failed pregnancy following assisted reproductive techniques. Hum Reprod. 2000;15(8):1717–22.
Larson-Cook KL, Brannian JD, Hansen KA, et al. Relationship between the outcomes of assisted reproductive techniques and sperm DNA fragmentation as measured by the sperm chromatin structure assay. Fertil Steril. 2003;80(4):895–902.
Muratori M, Maggi M, Spinelli S, et al. Spontaneous DNA fragmentation in swim-up selected human spermatozoa during long term incubation. J Androl. 2003;24:253–62.
Bungum M, Humaidan P, Axmon A, et al. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum Reprod. 2007;22:174–9.
Bakos HW, Thompson JG, Feil D, et al. Sperm DNA damage is associated with assisted reproductive technology pregnancy. Int J Androl. 2008;31(5):518–26.
Esterhuizen AD, Franken DR, Lourens JGH, et al. Sperm chromatin packing as an indicator of in-vitro fertilization rate. Hum Reprod. 2000;15(3):657–61.
Host E, Lindenberg S, Smidt-Jensen S. The role of DNA strand breaks in human spermatozoa used for IVF and ICSI. Acta Obstet Gynecol Scand. 2000;79:559–63.
Tomlinson MJ, Moffatt O, Manicardi GC, et al. Interrelationships between seminal parameters and sperm nuclear DNA damage before and after density gradient centrifugation: implications for assisted conception. Hum Reprod. 2001;16(10):2160–5.
Benchaib M, Braun V, Lornage J, et al. Sperm DNA fragmentation decreases the pregnancy rate in an assisted reproductive technique. Hum Reprod. 2003;18(5):1023–8.
Henkel R, Kierspel E, Hajimohammad M, et al. DNA fragmentation of spermatozoa and assisted reproduction technology. Reprod Biomed Online. 2003;7:477–84.
Adams C, Anderson L, Wood S. High, but not moderate, levels of sperm DNA fragmentation are predictive of poor outcome in egg donation cycles. Fertil Steril. 2004;82(2):S44.
Chohan KR, Griffin JT, Lafromboise M, et al. Sperm DNA damage relationship with embryo quality and pregnancy outcome in IVF patients. Fertil Steril. 2004;82(2):S55–6.
Gandini L, Lombardo F, Paoli D, et al. Full-term pregnancies achieved with ICSI despite high levels of sperm chromatin damage. Hum Reprod. 2004;19(6):1409–17.
Henkel R, Hajimohammad M, Stalf T, et al. Influence of deoxyribonucleic acid damage on fertilization and pregnancy. Fertil Steril. 2004;81(4):965–72.
Huang CC, Lin DPC, Tsao HM, et al. Sperm DNA fragmentation negatively correlates with velocity and fertilization rates but might not affect pregnancy rates. Fertil Steril. 2005;84(1):130–40.
Payne JF, Raburn DJ, Couchman GM, et al. Redefining the relationship between sperm deoxyribonucleic acid fragmentation as measured by the sperm chromatin structure assay and outcomes of assisted reproductive techniques. Fertil Steril. 2005;84:356–64.
Borini A, Tarozzi N, Bizzaro D, et al. Sperm DNA fragmentation: paternal effect on early post-implantation embryo development in ART. Hum Reprod. 2006;21(11):2876–81.
Bakos HW, Thompson JG, Lane M. Sperm DNA damage: is altered carbohydrate metabolism to blame? Fertil Steril. 2007;88(1):S48–9.
Benchaib M, Lornage J, Mazoyer C, et al. Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome. Fertil Steril. 2007;87(1):93–101.
Lin HH, Lee RK, Li SH, et al. Sperm chromatin structure assay parameters are not related to fertilization rates, embryo quality, and pregnancy rates in in vitro fertilization and intracytoplasmic sperm injection, but might be related to spontaneous abortion rates. Fertil Steril. 2008;90(2):352–9.
Cebesoy FB, Aydos K, Unlu C. Effect of sperm chromatin damage on fertilization ratio and embryo quality post-ICSI. Arch Androl. 2006;52:397–402.
Sakkas D, Urner F, Bianchi PG, et al. Sperm chromatin anomalies can influence decondensation after intracytoplasmic sperm injection. Hum Reprod. 1996;11:837–43.
Jones GM, Trounson AO, Lolatgis N, et al. Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil Steril. 1998;70:1022–9.
Seli E, Gardner DK, Schoolcraft WB, et al. Extent of nuclear DNA damage in ejaculated spermatozoa impacts on blastocyst development after in vitro fertilization. Fertil Steril. 2004;82(2):378–83.
Virro MR, Larson-Cook KL, Evenson DP. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles. Fertil Steril. 2004;81(5):1289–95.
Braude P, Bolton V, Moore S. Human gene expression first occurs between the four and eight-cell stages of preimplantation development. Nature. 1988;332:459–61.
Muriel L, Garrido N, Fernández JL, et al. Value of the sperm DNA fragmentation level, measured by the sperm chromatin dispersion (SCD) test, in the IVF and ICSI outcome. Fertil Steril. 2006;85:371–83.
Li TC. Guides for practitioners. Recurrent miscarriage: principles of management. Hum Reprod. 1998;13:478–82.
Duran EH, Morshedi M, Taylor S, et al. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Hum Reprod. 2002;17:3122–8.
Bungum M, Humaidan P, Spano M, et al. The predictive value of sperm chromatin structure assay (SCSA) parameters for the outcome of intrauterine insemination, IVF and ICSI. Hum Reprod. 2004;19(6):1401–8.
Boe-Hansen GB, Fedder J, Ersboll AK. The sperm chromatin structure assay as a diagnostic tool in the human fertility clinic. Hum Reprod. 2006;21(6):1576–82.
Ahmadi A, Ng SC. Fertilizing ability of DNA-damaged spermatozoa. J Exp Zool. 1999;284:696–704.
Banerjee S, Lamond S, McMahon A, et al. Does blastocyst culture eliminate paternal chromosomal defects and select good embryos? Inheritance of an abnormal paternal genome following ICSI. Hum Reprod. 2000;15:2455–9.
Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum Reprod Update. 2003;9:331–45.
Collins JA, Barnhart KT, Schlegel PN. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization? Fertil Steril. 2008;89(4):823–31.
Aitken RJ, de Iuliis GN, McLachlan RI. Biological and clinical significance of DNA damage in the male germ line. Int J Androl. 2008;32:46–56.
Fernadez-Gonzalez R, Moreira PN, Perez-Crespo M, et al. Long-term effects of mouse intracytoplasmic sperm injection with DNA-fragmented sperm on health and behavior of adult off-spring. Biol Reprod. 2008;78:761–72.
Lewis SE, Sterling ES, Young IS, et al. Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril. 1997;67:142–7.
Wolf AM, Asoh S, Hiranuma H. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem. 2010;21(5):381–9.
Kovalski NN, de Lamirande E, Gagnon C. Reactive oxygen species generated by human neutrophils inhibit sperm motility: protective effect of seminal plasma and scavengers. Fertil Steril. 1992;5S:809–16.
Aitken RJ, Buckingham D, Harkiss D. Use of a xanthine oxidase free radical generating system to investigate the cytotoxic effects of reactive oxygen species on human spermatozoa. J Reprod Fertil. 1993;97:441–50.
Griveau JF, Le Lannou D. Effects of antioxidants on human sperm preparation techniques. Int J Androl. 1994;17:225–31.
Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med. 1993;14:303–11.
Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl. 2006;29:569–75.
Dawson EB, Harris WA, Teter MC, et al. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril. 1992;58:1034–9.
Vezina D, Mauffette F, Roberts KD, et al. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res. 1996;53:65–83.
Lenzi A, Lombardo F, Sgro P, Salacone P, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79:292–300.
Eskenazi B, Kidd SA, Marks AR, et al. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod. 2005;20:1006–12.
Safarinejad MR, Safarinejad S. Efficacy of selenium and/or Nacetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181:741–51.
Scott R, MacPherson A, Yates RW, et al. The effect of oral selenium supplementation on human sperm motility. Br J Urol. 1998;82:76–80.
Comhaire FH, Christophe AB, Zaiata AA, et al. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fatty Acids. 2000;63:159–65.
Lenzi A, Sgro P, Salacone P, et al. A placebo-controlled double-blind randomized trial in the use of combined L-carnitineand l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81:1578–84.
Wong WY, Merkus HMWM, Thomas CMG, et al. Effects of folic acid and zinc sulphate on male factor subfertility: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2002;77:491–8.
Ebisch IMW, Pierik FH, de Jong FH, et al. Does folic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl. 2006;29:339–45.
Keskes-Ammar L, Feki-Chakroun N, Rebai T, et al. Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl. 2003;49:83–94.
Lenzi A, Culasso F, Gandini L, et al. Placebo-controlled, double-blind, crossover trial of glutathione therapy in male infertility. Hum Reprod. 1993;8:1657–62.
Lenzi A, Lombardo F, Gandini L, et al. Glutathione therapy for male infertility. Arch Androl. 1992;29:65–8.
Lenzi A, Picardo M, Gandini L, et al. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod. 1994;9:2044–50.
Abel BJ, Carswell G, Elton R, et al. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br J Urol. 1982;54:780–4.
Kessopoulou E, Powers HJ, Sharma KK, et al. A double-blind randomized placebo crossover controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 1995;64:825–31.
Moilanen J, Hovatta O. Excretion of alpha-tocopherol into human seminal plasma after oral administration. Andrologia. 1995;27:133–6.
Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod. 1999;14:1028–33.
Geva E, Bartoov B, Zabludovsky N, et al. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril. 1996;66:430–4.
Greco E, Iacobelli M, Rienzi L, et al. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. 2005;26(3):349–53.
Greco E, Romano S, Iacobelli M. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod. 2005;20(9):2590–4.
Menezo YJR, Hazout A, Panteix G, et al. Antioxidants to reduce sperm DNA fragmentation: an unexpected adverse effect. Reprod Biomed Online. 2007;14:418–21.
Piomboni P, Gambera L, Serafini F, et al. Sperm quality improvement after natural anti-oxidant treatment of asthenoteratospermic men with leukocytospermia. Asian J Androl. 2008;10:201–6.
Comhaire FH, El Garem Y, Mahmoud A, et al. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl. 2005;7:257–62.
Young SS, Eskenazi B, Marchetti FM, et al. The association of foliate, zinc, and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod. 2008;23:1014–22.
Suleiman SA, Ali ME, Zaki ZM, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17:530–7.
Tremellen K, Miari G, Froiland D, et al. A randomized control trial of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol. 2007;47:216–21.
Zalata A, Hafez T, Comhaire F. Evaluation of the role of reactive oxygen species in male infertility. Hum Reprod. 1995;10:1444–51.
Chi HJ, Kim JH, Ryu CS, et al. Protective effect of antioxidant supplementation in sperm-preparation medium against oxidative stress in human spermatozoa. Hum Reprod. 2008;23(5):1023–8.
Lamond S, Watkinson M, Rutherford T, et al. Gene-specific chromatin damage in human spermatozoa can be blocked by antioxidants that target mitochondria. Reprod Biomed Online. 2003;7:407–18.
Donnelly ET, McClure N, Lewis SE. The effect of ascorbate and alpha-tocopherol supplementation in vitro on DNA integrity and hydrogen peroxide-induced DNA damage in human spermatozoa. Mutagenesis. 1999;14:505–12.
Hammadeh ME, Askari AS, Georg T, et al. Effect of freeze-thawing procedure on chromatin stability, morphological alteration and membrane integrity of human spermatozoa in fertile and subfertile men. Int J Androl. 1999;22:155–62.
de Paula TS, Bertolla RP, Spaine DM. Effect of cryopreservation on sperm apoptotic deoxyribonucleic acid fragmentation in patients with oligozoospermia. Fertil Steril. 2006;86:597–600.
Thomson LK, Fleming SD, Aitken RJ. Cryopreservation-induced human sperm DNA damage is predominantly mediated by oxidative stress rather than apoptosis. Hum Reprod. 2009;24(9):2061–70.
Tremellen K. Oxidative stress and male infertility – a clinical perspective. Hum Reprod Update. 2008;14(3):243–58.
Kefer JC, Agarwal A, Sabanegh E. Role of antioxidants in the treatment of male infertility. Int J Urol. 2009;16:449–57.
Kao SH, Chao HT, Chen HW, Hwang TIS, Liao TL, Wei YH. Increase of oxidative stress in human sperm with lower motility. Fertil Steril. 2008;89(5):1183–90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Simon, L., Lewis, S.E.M. (2011). Basic and Clinical Aspects of Sperm Comet Assay. In: Zini, A., Agarwal, A. (eds) Sperm Chromatin. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6857-9_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6857-9_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1781-2
Online ISBN: 978-1-4419-6857-9
eBook Packages: MedicineMedicine (R0)